Skip to main content
BSF ENTERPRISE PLC logo

BSF ENTERPRISE PLC — Investor Relations & Filings

Ticker · BSFA ISIN · GB00BHNBDQ51 LEI · 2138007PJT69H8FYLC06 IL Professional, scientific and technical activities
Filings indexed 171 across all filing types
Latest filing 2022-11-23 Regulatory Filings
Country GB United Kingdom
Listing IL BSFA

About BSF ENTERPRISE PLC

https://bsfenterprise.com/

BSF Enterprise PLC is a biotechnology company that develops and commercializes cell-based, tissue-engineered solutions. The company focuses on creating innovative materials and products for various applications, including cultivated meat, lab-grown leather, and technologies for corneal repair. The core business model involves acquiring and advancing proprietary technologies in cellular agriculture and regenerative medicine with the objective of licensing its intellectual property.

Recent filings

Filing Released Lang Actions
3D Bio-Tissues partners with cell growth company
Regulatory Filings Classification · 100% confidence The document begins with 'RNS Number : 2805H' and is dated '23 November 2022'. It announces a specific business event: a partnership between BSF Enterprise PLC's subsidiary and Qkine to accelerate cultivated meat production. The text structure, including the RNS header, the announcement of a specific corporate event (partnership), and the concluding boilerplate information referencing RNS and the London Stock Exchange, strongly indicates this is a general regulatory news service announcement. Since it is not a full financial report (10-K, IR), a specific voting result (DVA), or a management change (MANG), the most appropriate classification is the general regulatory filing category, RNS.
2022-11-23 English
Successful Prototypes of Lab-Grown Fillets of Meat
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 3737G' and contains boilerplate language referencing 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. This strongly indicates a regulatory news service announcement. The content itself is a press release announcing a significant operational milestone (successful prototypes of lab-grown meat fillets) by BSF Enterprise PLC. Since this is a general, timely announcement of corporate news that doesn't fit the specific categories like Earnings Release (ER), Director's Dealing (DIRS), or Capital Change (CAP), and it is distributed via the RNS system, the most appropriate classification is the general regulatory filing/announcement category.
2022-11-15 English
3D Bio-Tissues receives €100,000 grant
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 3090E' and is dated '27 October 2022'. It details an announcement from BSF Enterprise PLC regarding its subsidiary receiving a €100,000 grant for developing serum-free media. The text concludes with standard boilerplate language referencing 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. This structure is characteristic of a general regulatory news service announcement, which fits the definition of Regulatory Filings (RNS) as a miscellaneous regulatory announcement that doesn't fit a more specific category like ER, DIV, or DIRS.
2022-10-27 English
3D Bio-Tissues Appoints Business Director
Board/Management Information Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content announces a specific corporate event: the appointment of a new Business Director for a subsidiary to commercialize a product. This type of material, which is a formal announcement distributed via the London Stock Exchange's regulatory news service (RNS) but does not fit into specific categories like Director's Dealing (DIRS), Earnings Release (ER), or Capital Change (SHA), falls best under the general Regulatory Filings category (RNS) as defined in the provided schema, which serves as a fallback for miscellaneous regulatory announcements.
2022-09-21 English
Operational Update
Regulatory Filings Classification · 99% confidence The document is identified by the header 'RNS Number : 7237S' and contains an 'Operational Update' regarding production capacity expansion, patent progress, and M&A discussions. It is a brief announcement providing key operational highlights and commentary, rather than a full financial report (like 10-K or IR) or a formal transcript. Since it is a general, timely announcement released via the RNS system (which is explicitly mentioned at the end), and it doesn't fit perfectly into specific categories like ER, DIV, or DIRS, it falls best under the general regulatory announcement category, RNS, or potentially an Investor Presentation (IP) if it were more presentation-like. Given the format is a news release detailing operational progress and future plans, RNS is the most appropriate general classification for a non-standard regulatory update.
2022-07-18 English
Special Resolution passed at AGM
AGM Information Classification · 98% confidence The document explicitly states it is a 'SPECIAL RESOLUTION OF BSF ENTERPRISE PLC' passed 'At the Annual General Meeting'. This content—a specific resolution passed during the AGM—is directly related to the proceedings and outcomes of that meeting. While it is a resolution, the context of it being passed *at* the AGM strongly suggests it is material shared during or immediately following the Annual General Meeting. Therefore, the most appropriate classification is AGM Information (AGM-R). The document length is very short (702 chars), but it contains the core content (the resolution itself) rather than just announcing that AGM materials are available, making AGM-R more specific than RPA or RNS.
2022-07-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.